438 related articles for article (PubMed ID: 25068994)
1. The role of the oncofetal IGF2 mRNA-binding protein 3 (IGF2BP3) in cancer.
Lederer M; Bley N; Schleifer C; Hüttelmaier S
Semin Cancer Biol; 2014 Dec; 29():3-12. PubMed ID: 25068994
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?
Bell JL; Wächter K; Mühleck B; Pazaitis N; Köhn M; Lederer M; Hüttelmaier S
Cell Mol Life Sci; 2013 Aug; 70(15):2657-75. PubMed ID: 23069990
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in cancer.
Huang X; Zhang H; Guo X; Zhu Z; Cai H; Kong X
J Hematol Oncol; 2018 Jun; 11(1):88. PubMed ID: 29954406
[TBL] [Abstract][Full Text] [Related]
4. Subcellular localization and RNP formation of IGF2BPs (IGF2 mRNA-binding proteins) is modulated by distinct RNA-binding domains.
Wächter K; Köhn M; Stöhr N; Hüttelmaier S
Biol Chem; 2013 Aug; 394(8):1077-90. PubMed ID: 23640942
[TBL] [Abstract][Full Text] [Related]
5. IGF2BP1 enhances an aggressive tumor cell phenotype by impairing miRNA-directed downregulation of oncogenic factors.
Müller S; Bley N; Glaß M; Busch B; Rousseau V; Misiak D; Fuchs T; Lederer M; Hüttelmaier S
Nucleic Acids Res; 2018 Jul; 46(12):6285-6303. PubMed ID: 29660014
[TBL] [Abstract][Full Text] [Related]
6. EGR2-mediated regulation of m
Ying Y; Ma X; Fang J; Chen S; Wang W; Li J; Xie H; Wu J; Xie B; Liu B; Wang X; Zheng X; Xie L
Cell Death Dis; 2021 Jul; 12(8):750. PubMed ID: 34326314
[TBL] [Abstract][Full Text] [Related]
7. IGF2BP family of RNA-binding proteins regulate innate and adaptive immune responses in cancer cells and tumor microenvironment.
Elcheva IA; Gowda CP; Bogush D; Gornostaeva S; Fakhardo A; Sheth N; Kokolus KM; Sharma A; Dovat S; Uzun Y; Schell TD; Spiegelman VS
Front Immunol; 2023; 14():1224516. PubMed ID: 37503349
[TBL] [Abstract][Full Text] [Related]
8. miR-1275: A single microRNA that targets the three IGF2-mRNA-binding proteins hindering tumor growth in hepatocellular carcinoma.
Fawzy IO; Hamza MT; Hosny KA; Esmat G; El Tayebi HM; Abdelaziz AI
FEBS Lett; 2015 Aug; 589(17):2257-65. PubMed ID: 26160756
[TBL] [Abstract][Full Text] [Related]
9. Abrogating the interplay between IGF2BP1, 2 and 3 and IGF1R by let-7i arrests hepatocellular carcinoma growth.
Fawzy IO; Hamza MT; Hosny KA; Esmat G; Abdelaziz AI
Growth Factors; 2016 Feb; 34(1-2):42-50. PubMed ID: 27126374
[TBL] [Abstract][Full Text] [Related]
10. Posttranscriptional destabilization of the liver-specific long noncoding RNA HULC by the IGF2 mRNA-binding protein 1 (IGF2BP1).
Hämmerle M; Gutschner T; Uckelmann H; Ozgur S; Fiskin E; Gross M; Skawran B; Geffers R; Longerich T; Breuhahn K; Schirmacher P; Stoecklin G; Diederichs S
Hepatology; 2013 Nov; 58(5):1703-12. PubMed ID: 23728852
[TBL] [Abstract][Full Text] [Related]
11. IMPs: an RNA-binding protein family that provides a link between stem cell maintenance in normal development and cancer.
Degrauwe N; Suvà ML; Janiszewska M; Riggi N; Stamenkovic I
Genes Dev; 2016 Nov; 30(22):2459-2474. PubMed ID: 27940961
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor formation and invasion and predicts poor prognosis in oral squamous cell carcinoma.
Lin CY; Chen ST; Jeng YM; Yeh CC; Chou HY; Deng YT; Chang CC; Kuo MY
J Oral Pathol Med; 2011 Oct; 40(9):699-705. PubMed ID: 23647076
[TBL] [Abstract][Full Text] [Related]
13. Identification of characteristic IGF2BP expression patterns in distinct B-ALL entities.
Stoskus M; Gineikiene E; Valceckiene V; Valatkaite B; Pileckyte R; Griskevicius L
Blood Cells Mol Dis; 2011 Apr; 46(4):321-6. PubMed ID: 21414819
[TBL] [Abstract][Full Text] [Related]
14. Co-transcriptional R-loops-mediated epigenetic regulation drives growth retardation and docetaxel chemosensitivity enhancement in advanced prostate cancer.
Ying Y; Wu Y; Zhang F; Tang Y; Yi J; Ma X; Li J; Chen D; Wang X; Liu X; Liu B; Luo J; Zheng X; Xie L
Mol Cancer; 2024 Apr; 23(1):79. PubMed ID: 38658974
[TBL] [Abstract][Full Text] [Related]
15. A pan-cancer landscape of IGF2BPs and their association with prognosis, stemness and tumor immune microenvironment.
Shao W; Zhao H; Zhang S; Ding Q; Guo Y; Hou K; Kan Y; Deng F; Xu Q
Front Oncol; 2022; 12():1049183. PubMed ID: 36686749
[TBL] [Abstract][Full Text] [Related]
16. Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential.
Zhu TY; Hong LL; Ling ZQ
Biomark Res; 2023 Jun; 11(1):62. PubMed ID: 37280679
[TBL] [Abstract][Full Text] [Related]
17. IGF2BP1: a post-transcriptional "driver" of tumor cell migration.
Stöhr N; Hüttelmaier S
Cell Adh Migr; 2012; 6(4):312-8. PubMed ID: 22983196
[TBL] [Abstract][Full Text] [Related]
18. Recognition of RNA N
Huang H; Weng H; Sun W; Qin X; Shi H; Wu H; Zhao BS; Mesquita A; Liu C; Yuan CL; Hu YC; Hüttelmaier S; Skibbe JR; Su R; Deng X; Dong L; Sun M; Li C; Nachtergaele S; Wang Y; Hu C; Ferchen K; Greis KD; Jiang X; Wei M; Qu L; Guan JL; He C; Yang J; Chen J
Nat Cell Biol; 2018 Mar; 20(3):285-295. PubMed ID: 29476152
[TBL] [Abstract][Full Text] [Related]
19. The oncofetal RNA-binding protein IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression in cancer.
Müller S; Bley N; Busch B; Glaß M; Lederer M; Misiak C; Fuchs T; Wedler A; Haase J; Bertoldo JB; Michl P; Hüttelmaier S
Nucleic Acids Res; 2020 Sep; 48(15):8576-8590. PubMed ID: 32761127
[TBL] [Abstract][Full Text] [Related]
20. The Roles of Insulin-Like Growth Factor 2 mRNA-Binding Protein 2 in Cancer and Cancer Stem Cells.
Cao J; Mu Q; Huang H
Stem Cells Int; 2018; 2018():4217259. PubMed ID: 29736175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
